PATRICIA BRADT: Open Payments
NPI 1548755440 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,087 in 110 payments from 22 companies in 2025. Trend: 2023 $2,147 · 2024 $2,212 · 2025 $2,087
Food & beverage: $2,087
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $427 |
| AstraZeneca Pharmaceuticals LP | 11 | $295 |
| Novo Nordisk Inc | 12 | $242 |
| GlaxoSmithKline, LLC. | 17 | $237 |
| MERZ NORTH AMERICA, INC. | 1 | $149 |
| Lilly USA, LLC | 6 | $116 |
| Renalytix AI, Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Indivior Inc. | 3 | $64 |
Products named: VRAYLAR, TRELEGY ELLIPTA, BREZTRI, Ozempic, FARXIGA, Wegovy, UBRELVY, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.
Industry payments across NY — which companies pay providers there.
